Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
104.66
-0.08 (-0.08%)
Sep 2, 2026, 11:57 AM EDT - Market open
Rhythm Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Hold Initiates $120 | Hold | Initiates | $120 | +14.66% | Aug 28, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $150 | Buy | Reiterates | $150 | +43.32% | Aug 25, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $143 | Buy | Reiterates | $143 | +36.63% | Aug 25, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $146 | Buy | Reiterates | $146 | +39.50% | Aug 10, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $141 → $155 | Buy | Reiterates | $141 → $155 | +48.10% | Aug 5, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $151 → $154 | Buy | Maintains | $151 → $154 | +47.14% | Aug 5, 2026 |
| Citi | Citi | Buy Maintains $142 → $143 | Buy | Maintains | $142 → $143 | +36.63% | Aug 5, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $155 → $160 | Buy | Maintains | $155 → $160 | +52.88% | Aug 5, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.